COVID-19 Clinical Trials

Find COVID-19 Clinical Trials Near You

Feasibility of ENGAGE to Address Social Isolation Related to the COVID-19 Pandemic

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a single-arm community-based feasibility study examining recruitment, retention, adherence, and satisfaction with ENGAGE, a community-based intervention designed to address pandemic-related social isolation among people with disabilities. We will also examine preliminary, within-group effects on social participation. The findings of this study will inform a larger trial to examine intervention efficacy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Self-identify as disabled

• Report problems with social participation

• Speak English

• Live in a community setting

Locations
United States
Illinois
University of Illinois Chicago
RECRUITING
Chicago
Contact Information
Primary
Joy Hammel, PhD
hammel@uic.edu
(312) 996-3513
Backup
Jessica Kersey, PhD
jmkersey@uic.edu
Time Frame
Start Date: 2023-04-01
Estimated Completion Date: 2026-01-31
Participants
Target number of participants: 21
Treatments
Experimental: ENGAGE
ENGAGE uses social learning, guided problem-solving and applied skill training to promote social participation among people with disabilities within the context of the COVID-19 pandemic. This is a group intervention using a self-management framework.
Related Therapeutic Areas
Sponsors
Leads: University of Illinois at Chicago
Collaborators: National Center for Advancing Translational Sciences (NCATS)

This content was sourced from clinicaltrials.gov